Results of independent clinical validation study of Almac-developed ColDx assay presented at ASCO-GI
Data shows assay to be a significant predictor of risk of recurrence in stage II colon cancer
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.